01
Major Shareholders (Top 10)
Top 10 shareholders with shareholding ratio
April 13, 2025
|
CURRENT SHAREHOLDING
|
SHARES
|
%
|
|---|---|---|
|
Tong-Hsuan Chang
|
4,309,092 |
3.97%
|
| The representative of Taiwan Advanced Biopharma Inc. | 3,122,919 | 2.88% |
| The investment portfolios of Otsuka Pharmaceutical Co., Ltd. Entrust and manage by Mega International Commercial Bank |
3,036,000
|
2.80%
|
| Hsiu E. Su |
2,204,489
|
2.03%
|
| Kun-Chang, Li |
2,065,000
|
1.90%
|
| Huarong, Lian |
1,496,000
|
1.38%
|
| Cai -Qing Hong |
1,326,485
|
1.22%
|
| The representative of Rong Jing Development Investment Co., Ltd. | 1,152,000 | 1.06% |
| Jing-Yang, Chen |
1,130,000
|
1.04%
|
| The investment portfolios of Sui Feng Co., Ltd. entrust and manage by BANK SINOPAC COMPANY LIMITEDk |
1,122,256
|
1.03%
|
03
Annual Reports
04
Market Observation Post System
Our company currently does not offer electronic processing of shareholder services as governed by the Electronic Signatures Act. Shareholders are requested to continue using the current application method by submitting written documents affixed with their registered seal to the company’s transfer agent (or shareholder services unit).
In accordance with regulations, our company will disclose "important information" on the M.O.P.S (Market Observation Post System) from time to time and in real time.
You can link to the M.O.P.S (Market Observation Post System) and enter the code "GlycoNex Inc." (4168)
本公司依規定，將不定期、即時揭露「股利分派情形」於公開資訊觀測站。
可連結至公開資訊觀測站並請輸入「台灣醣聯生技醫藥股份有限公司」代號 ( 4168 )